944PQUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset. (23rd October 2018) - Moore, K N; Secord, A A; Geller, M; Miller, D S; Cloven, N G; Fleming, G F; Wahner Hendrickson, A E; Azodi, M; DiSilvestro, P; Oza, A; Cristea, M; Berek, J S; et al.